Cytokeratin-positive meningeal peripheral PNET/Ewing's sarcoma of the cervical spinal cord: Diagnostic value of genetic analysis

International Journal of Surgical Pathology

Volumn 13, Issue 1, 2005, Pages 93-97

  Woestenborghs, Heidi ^a   Debiec Rychter, Maria ^a   Renard, Marleen ^a   Demaerel, Philippe ^a   Van Calenbergh, Frank ^a   Van Gool, Stefaan ^a   Sciot, Raf ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Cytokeratin; Ewing's sarcoma; Meninges; Primitive neuroectodermal tumor; Spinal cord; Synovial sarcoma; t(11; 22)

Indexed keywords

CD99 ANTIGEN; CYTOKERATIN; TUMOR MARKER;

ARTICLE; CASE REPORT; CENTRAL NERVOUS SYSTEM; CERVICAL SPINAL CORD; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 22; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; EWING SARCOMA; GENE REARRANGEMENT; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MENINGIOMA; NEUROECTODERM TUMOR; PRIORITY JOURNAL; SCHOOL CHILD; SPINAL CORD TUMOR; SYNOVIAL SARCOMA; TUMOR DIFFERENTIATION;

EID: 13544253721     PISSN: 10668969     EISSN: None     Source Type: Journal    
DOI: 10.1177/106689690501300114     Document Type: Article

References (9)

1. Paulussen M, Frohlich B, Jurgens H. Ewing tumor: Incidence, prognosis and treatment options. Paediatr Drugs 3:899-913, 2001
2. Dei Tos AP, Wadden C, Calonje E, et al. Immunohistochemical demonstration of glycoprotein p30/32MIC2 (CD99) in synovial sarcoma: A potential cause of diagnostic confusion. Appl Immunohistochem 3:168-173, 1995
3. Arvand A, Denny CT. Biology of EWS/ETS fusions in Ewings's family tumors. Oncogene 20:5747-5754, 2001
4. Dedeurwaerdere F, Giannini C, Sciot R, Rubin BP, Perilongo G, Borghi L, et al. Primary peripheral PNET/Ewing's sarcoma of the dura: A clinicopathological entity distinct from central PNET. Mod Pathol 15:673-678, 2002
5. Machen K, Fisher C, Gautam, Tubbs, Goldblum JR. Utility of cytokeratin subsets for distinguishing poorly differentiated synovial sarcoma from peripheral primitive neuroectodermal tumor. Histopathology 33:501-507, 1998
6. Mai G, Antonescu CR, Guiter G, Huvos AG, Ladanyi M, Zakowski MP. Cytokeratin immunoreactivity in Ewing's sarcoma. Am J Surg Pathol 24:410-416, 2000
7. Nielsen TO, Hsu FD, O'Connell JX, Gilks CB, Sorensen PHB, Linn S, West RB, Liu CL, Botstein D, Brown PO, van de Rijn M. Tissue microarray validation of epidermal growth factor receptor and SALL2 in synovial sarcoma with comparison to tumors of similar histology. Am J Pathol 163:1449-1456, 2003
8. de Alava E, Kawai A, Healey JH, Fligman I, Meyers PA, Huvos AG, et al. EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma. J Clin Oncol 16:1248-1255, 1998
9. de Alava E, Panizo A, Antonescu CR, Huvos AG, Pardo-Mindan FJ, Barr FG, et al. Association of EWS-FLI1 type-1 fusion with lower proliferative rate in Ewing's sarcoma. Am J Pathol 156:849-855, 2000